Fourier transform infrared microspectroscopic analysis identifies alterations in mineral properties in bones from mice transgenic for type X collagen.

Type X collagen has been implicated in the morphogenetic events of endochondral ossification (EO), including the calcification of hypertrophic cartilage and trabeculae prior to their replacement by bone and marrow. Recently, transgenic mice, which expressed a truncated collagen X protein, were reported to exhibit morphologic alterations in all tissues arising through EO. Specifically, the growth plates were compressed within the zone of cartilage hypertrophy, and the number and size of calcified trabeculae were reduced. The condition in the mouse is comparable to Schmid metaphyseal chondrodysplasia in humans for which, to date, 20 defined type X collagen mutations have been reported. The transgenic mouse showed no alterations in mineralization by conventional histology, however, it did show a decrease in newly formed bony trabeculae, and a thinning of periosteal bones. Fourier transform infrared (FTIR) spectroscopy has previously been shown to provide quantitative and qualitative information about the relative amount of mineral and carbonate present, mineral composition, and crystal perfection. To determine whether the expression of abnormal collagen X molecules had an effect on mineral properties, the "quality" of mineral crystals was analyzed in thin sections of tibia from day 17 and day 25 genotypically negative (normal) and positive (mutant) mice from several independent transgenic mouse lines showing varying degrees of the mutant phenotype, by means of Fourier transform infrared microscopic analysis (FTIRM). The results indicate definite differences between normal and transgenic mice calcified cartilage mineral, both in the amount present and the "quality" of the crystals. Calcified cartilage mineral from transgenic mice exhibited less crystallinity and higher acidic phosphate content than the corresponding mineral from normal specimens.

[1]  B. Olsen,et al.  Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition , 1993, Nature.

[2]  J. T. Thomas,et al.  Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid. , 1994, American journal of human genetics.

[3]  D. Prockop,et al.  An ultrastructural, microanalytical, and spectroscopic study of bone from a transgenic mouse with a COL1.A1 pro-alpha-1 mutation. , 1994, Bone.

[4]  B. Olsen,et al.  Skeletal and Hematopoietic Defects in Mice Transgenic for Collagen X a , 1996 .

[5]  D. Bonen,et al.  Elevated extracellular calcium concentrations induce type X collagen synthesis in chondrocyte cultures , 1991, The Journal of cell biology.

[6]  B. Olsen,et al.  Organization and regulation of collagen genes. , 1991, Critical reviews in eukaryotic gene expression.

[7]  B. Olsen,et al.  Structure, molecular biology, and pathology of collagen. , 1990, Annals of the New York Academy of Sciences.

[8]  T. Schmid,et al.  Hypertrophic Cartilage Matrix , 1990, Annals of the New York Academy of Sciences.

[9]  S. Jimenez,et al.  Effects of calcium deficiency on chondrocyte hypertrophy and type X collagen expression in chick embryonic sternum , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  A. Boskey,et al.  The effects of noncollagenous matrix proteins on hydroxyapatite formation and proliferation in a collagen gel system. , 1989, Connective tissue research.

[11]  J. Lian,et al.  Comparative morphological and biochemical analysis of hypertrophic, non-hypertrophic and 1,25(OH)2D3 treated non-hypertrophic chondrocytes. , 1990, Connective tissue research.

[12]  G. Freeman,et al.  Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. , 1993, Science.

[13]  R. Behringer,et al.  Normal long bone growth and development in type X collagen-null mice , 1994, Nature Genetics.

[14]  G. Gibson,et al.  Type X collagen synthesis by chick sternal cartilage and its relationship to endochondral development , 1985, The Journal of cell biology.

[15]  C. Farnum,et al.  Visualization of living terminal hypertrophic chondrocytes of growth plate cartilage in situ by differential interference contrast microscopy and time‐lapse cinematography , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  S. Jimenez,et al.  Biosynthetic expression of type X collagen in embryonic chick sternum cartilage during development. , 1986, The Journal of biological chemistry.

[17]  M. Abbott,et al.  Concentration of mutations causing schmid metaphyseal chondrodysplasia in the C‐terminal noncollagenous domain of type X collagen , 1995, Human mutation.

[18]  R Mendelsohn,et al.  Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals. , 1991, Biophysical journal.

[19]  B. Olsen,et al.  A dominant negative mutation in the alpha 1 (X) collagen gene produces spondylometaphyseal defects in mice. , 1993, Progress in clinical and biological research.

[20]  B. Olsen,et al.  A type X collagen mutation causes Schmid metaphyseal chondrodysplasia , 1993, Nature Genetics.

[21]  B. Olsen,et al.  Additional mutations of type X collagen confirm COL10A1 as the Schmid metaphyseal chondrodysplasia locus. , 1994, Human molecular genetics.

[22]  J. T. Thomas,et al.  Intron-exon structure, alternative use of promoter and expression of the mouse collagen X gene, Col10a-1. , 1993, European journal of biochemistry.

[23]  J. Lian,et al.  Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. , 1990, Endocrinology.